Carregant...
Targeted drugs in small-cell lung cancer
In contrast to non-small-cell lung cancer (NSCLC), few advances have been made in systemic treatment of small-cell lung cancer (SCLC) in recent years. Most patients are diagnosed with extensive stage disease and are commonly treated with platinum-based chemotherapy which, although attaining high ini...
Guardat en:
Publicat a: | Transl Lung Cancer Res |
---|---|
Autors principals: | , , , , , , |
Format: | Artigo |
Idioma: | Inglês |
Publicat: |
AME Publishing Company
2016
|
Matèries: | |
Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4758978/ https://ncbi.nlm.nih.gov/pubmed/26958493 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2218-6751.2016.01.12 |
Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|